Complementary strengths

MDRNA's approach to the development of RNAi-based therapeutics is founded on the natural precision of siRNA's to target and control the over-expression of disease-causing proteins. Our scientific expertise and discovery approach allows us to create optimal drug candidates that achieve high potency with lower risk of immunological response and reduced off-target activity.